Revalia Bio is a new startup that's building products which integrate software, hardware, and therapeutics to enable better decision making for patients and providers. At Revalia we develop our products in whole diseased human organs from deceased donors that are "brought back to life" outside of the body using perfusion technology. By starting our development with "first-in-human organ trials" we can rapidly accelerate the time it takes to bring new innovations in care to patients. We're working to deliver on a future where we can deliver on the promise of truly personalized medicine that has been discussed in the field for the last two decades.